Sygen Pharmaceuticals Limited, was established in March 2019 with the vision of creating a world class life sciences company focused on the West African region. Sygen subsequently acquired the physical and brand assets of Nigerian German Chemicals PLC in December of 2019 and commenced an extensive integration and transformation agenda in February 2020.
Our mission is to develop and create access to high quality medicines that yield successful outcomes and improve the quality of life of patients in the communities that we operate in.
Sygen manufactures over 16 categories of products in our world-class ISO and NAFDAC approved manufacturing facilities.
Press Release & Stories
Sygen Promotes Community Well-being, Drives Pharmaceutical Innovation
Sygen Pharma is at the forefront of driving innovation in the pharmaceutical industry with the aim of promoting overall communal well-being for all